Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease

Table 1 Baseline demographics of study population

Characteristic	Total population (n = 93)	Metabolic syndrome (n = 65)	No metabolic syndrome (n = 28)	^a *P value*
Omentin-1 (ng/mL)	149.2 ± 72.7	145.7 ± 70.0	157.4 ± 79.3	0.50
Sex (women/men)	47/46	32/33	15/13	0.70
Age (years)	48 ± 8	49 ± 8	45 ± 8	0.02
Current smokers	24 (25.8%)	16 (24.6%)	8 (12.3%)	0.69
BMI (kg/m²)	31.3 ± 4.7	32.1 ± 4.0	29.3 ± 5.6	0.02
Weight (kg)	91.6 ± 15.6	93.8 ± 13.4	86.4 ± 19.2	0.01
Systolic blood pressure (mm Hg)	129 ± 14	132 ± 14	121 ± 12	0.001
Diastolic blood pressure (mm Hg)	83 ± 12	85 ± 11	77 ± 13	0.002
Waist circumference (cm)	106.0 ± 11.8	108.6 ± 9.5	99.9 ± 14.4	0.001
Fasting plasma glucose (mg/dL)	93 ± 9	95 ± 10	89 ± 8	0.001
Impaired fasting glucose	28 (30.1%)	26 (40.0%)	2 (7.1%)	0.002
Total cholesterol (mg/dL)	187 ± 35	187 ± 37	185 ± 30	0.73
LDL cholesterol (mg/dL)	110 ± 29	109 ± 30	111 ± 25	0.80
HDL cholesterol (mg/dL)	44 ± 11	41 ± 10	50 ± 12	<0.001
Triglycerides (mg/dL)	166 ± 83	187 ± 80	118 ± 71	<0.001
White blood cell count (x 10⁹/L)	6.5 ± 2.0	6.4 ± 1.8	6.7 ± 2.4	0.60

Data are expressed as mean ± standard deviation or number (%). ^aP values are for comparisons of metabolic syndrome versus no metabolic syndrome. Plasma omentin-1 concentrations, expressed as median (interquartile range), were 137.2 ng/ml (94.2 to 186.8 ng/ml) in the total population, 133.1 ng/ml (93.5 to 184.8 ng/ml) in participants with the metabolic syndrome, and 137.4 ng/ml (104.5 to 196.2 ng/ml) in participants without the metabolic syndrome.

ISSN: 1758-5996